Drugs & TargetsFree HIF-2α inhibitor MK-6482 receives FDA Breakthrough Designation for Von Hippel-Lindau Disease-associated RCC July 31, 2020Vol.46 No.31
Drugs & TargetsFree Engineered macrophage immunotherapy receives IND clearance from FDA July 31, 2020Vol.46 No.31
Drugs & TargetsFree BDTX-189 receives FDA Fast Track Designation for solid tumors harboring HER2 or EGFR mutations July 31, 2020Vol.46 No.31
Drugs & TargetsFree Tagrisso receives FDA Breakthrough Therapy Designation for adjuvant treatment of stage IB-IIIA EGFR-mutated lung cancer July 31, 2020Vol.46 No.31
Drugs & TargetsFree Piqray receives approval in Europe for HR+/HER2- advanced breast cancer with a PIK3CA mutation July 31, 2020Vol.46 No.31
Clinical RoundupFree FDA, Syapse real-world study reveal higher risk of hospitalization and death among cancer patients with COVID-19, underscore health disparities July 31, 2020Vol.46 No.31
Clinical RoundupFree Clinical trial tests oral cancer drug to combat respiratory symptoms of COVID-19 July 31, 2020Vol.46 No.31
Clinical RoundupFree Fox Chase researchers examine treatment toxicities in older esophageal cancer patients July 31, 2020Vol.46 No.31
Clinical RoundupFree Artificial intelligence identifies prostate cancer with near-perfect accuracy July 31, 2020Vol.46 No.31
